Investigation of SGLT2 Variant Interaction with Empagliflozin and Sotagliflozin
Postprandial hyperglycemia, a hallmark of type 2 diabetes mellitus, is often mitigated through the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors, which function to lower blood glucose levels by promoting glucose excretion in the urine. Empagliflozin and sotagliflozin are examples of such...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
University of Mazandaran
2025-09-01
|
| Collection: | Journal of Genetic Resources |
| Sujets: | |
| Accès en ligne: | https://sc.journals.umz.ac.ir/article_5894_4b7e803ae2111c44fd9942a3bda2da52.pdf |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|